A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients

Supportive Care in Cancer

Volumn 15, Issue 6, 2007, Pages 613-620

  Suh, Sang Yeon ^a   Ahn, Hong Yup ^b  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

C reactive protein; Prognostic factor; Survival; Terminal cancer

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; FEMALE; HUMAN; HYPERBILIRUBINEMIA; LIFE EXPECTANCY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEROLOGY; SURVIVAL TIME; SYMPTOM; TERMINALLY ILL PATIENT; UNIVARIATE ANALYSIS; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERMINALLY ILL;

EID: 34447122724     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0208-5     Document Type: Article

References (32)

1. den Daas N (1995) Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 10:548-555
2. Geissbuhler P, Mermillod B, Rapin CH (2000) Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 20:93-103
3. Burtis CA, Ashwood ER (1999) Tietz textbook of clinical chemistry, 3rd ed. W.B. Saunders company, Philadelphia, p 132
4. Falconer JS, Fearon KC, Ross JA et al (1995) Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75:2077-2082
5. Nozoe T, Matsumata T, Kitamura M, Sugimachi K (1998) Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 176:335-338
6. Nozoe T, Saeki H, Sugimachi K (2001) Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 182:197-201
7. Kroschinsky F, Weise M, Illmer T et al (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294-1300
8. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454
9. Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 107:391-397
10. Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32:917-924
11. Tamakoshi K, Yatsuya H, Kondo T et al (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes 27:443-449
12. Nelson KA, Walsh D (2002) The cancer anorexia-cachexia syndrome: a survey of the prognostic inflammatory and nutritional index (PINI) in advanced disease. J Pain Symptom Manage 24:424-428
13. Mahmoud FA, Rivera NI (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4:250-255
14. Miki C, Konishi N, Ojima E et al (2004) C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49(6):970-976
15. McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170:319-322
16. Salvarani C, Cantini F, Niccoli L et al (2005) Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 53(1):33-38
17. Hashimoto K, Ikeda Y, Korenaga D et al (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:1856-1864
18. Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KC (2001) Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 88:255-260
19. Kinoshita T, Ito H, Miki C (1999) Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 85:2526-2531
20. Nozoe T, Matsumata T, Sugimachi K (2000) Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23(3):263-266
21. Grobbelaar EJ, Owen S, Torrance AD, Wilson JA (2004) Nutritional challenges in head and neck cancer. Clin Otolaryngol 29:307-313
22. McMillan DC, Scott HR, Watson WS et al (1998) Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31(2):101-105
23. O'Gorman P, McMillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37(1):36-40
24. Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 197:499-511
25. Legouffe E, Rodriguez C, Picot MC et al (1998) C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma 31(3-4):351-357
26. Mantovani G, Maccio A, Madeddu C et al (2002) Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 98:84-91
27. Vigano A, Donaldson N, Higginson IJ et al (2004) Quality of life and survival prediction in terminal cancer patients. A multicenter study. Cancer 101:1090-1098
28. Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage 17:231-239
29. Ripamonti C, Bruera E (1997) Dyspnea: pathophysiology and assessment. J Pain Symptom Manage 13:220-232
30. Hawkins WG, DeMatteo RP, Jarnagin WR et al (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11(3):310-315
31. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC (1993) Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7(3):199-204
32. Ueno H, Okada S, Okusaka T et al (2000) Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 59:296-301